Prostate cancer is the second most common cancer diagnosed in men worldwide, and it is the most frequently diagnosed cancer in men in over 100 countries . In the United States alone, approximately one in eight men will be diagnosed with prostate cancer during their lifetime .
Despite these staggering numbers, the good news is that when caught early, prostate cancer is highly treatable. This guide answers the fundamental question what is prostate cancer, explains prostate cancer symptoms and signs of prostate cancer, covers prostate cancer treatment options, discusses prostate cancer screening guidelines, and provides current prostate cancer survival rate statistics.
Whether you are experiencing symptoms from prostate cancer or simply want to educate yourself, this article will walk you through everything you need to know—including how to distinguish real symptoms of prostate cancer from benign conditions.
Note: You may see variations like prostate cancer sympotms (a common typo). Rest assured, this guide covers all correct medical terminology for prostate cancer symptoms.
Part 1: What Is Prostate Cancer?
Before discussing prostate cancer symptoms or treatment, it helps to understand the disease itself.
The Prostate Gland
The prostate is a small, walnut-sized gland located just below the bladder and in front of the rectum in people assigned male at birth . It wraps around the urethra (the tube that carries urine and semen out of the body). The prostate’s primary function is to produce seminal fluid, which nourishes and transports sperm.
What Happens in Prostate Cancer?
What is prostate cancer? Simply put, it is an abnormal, uncontrolled growth of cells within the prostate gland . These cells can multiply and form tumors. In some cases, the cancer remains confined to the prostate (localized). In others, it can grow into nearby tissues or spread (metastasize) to other parts of the body—most commonly the lymph nodes, bones, lungs, or liver .
Types of Prostate Cancer
- Adenocarcinoma (over 99% of cases): Begins in the gland cells that produce prostate fluid
- Other rare types: Small cell carcinoma, neuroendocrine tumors, transitional cell carcinoma, and sarcomas
Is Prostate Cancer Always Aggressive?
No. This is one of the most important facts about what is prostate cancer. Many prostate cancers grow very slowly and may never cause symptoms or health problems during a man’s lifetime . Some men die with prostate cancer, not from it. However, other types are aggressive and spread quickly. Distinguishing between these two types is the goal of modern screening and diagnosis.
Part 2: Prostate Cancer Symptoms and Signs
One of the biggest challenges with prostate cancer is that prostate cancer symptoms often do not appear until the disease is advanced. In its early stages, prostate cancer is usually asymptomatic (causes no symptoms at all) .
However, when symptoms of prostate cancer do occur, they generally fall into two categories: those caused by the local growth of the tumor and those caused by metastasis (spread).
Early Prostate Cancer Symptoms (Local Growth)
As the tumor enlarges, it can press on the urethra or bladder, causing urinary changes. Signs of prostate cancer related to local growth include:
| Symptom | Description |
|---|---|
| Frequent urination | Needing to urinate more often, especially at night (nocturia) |
| Urgent urination | A sudden, strong need to urinate immediately |
| Weak urine stream | Difficulty starting or maintaining urine flow |
| Intermittent stream | Urine flow that starts and stops |
| Dribbling | Leaking urine after finishing |
| Incomplete emptying | Feeling that the bladder is not fully empty |
| Painful urination | Burning or discomfort while urinating (dysuria) |
| Blood in urine | Hematuria (red or pink urine) |
| Blood in semen | Hematospermia (pink or red semen) |
| Erectile dysfunction | Difficulty achieving or maintaining an erection |
Advanced Prostate Cancer Symptoms (Metastasis)
When prostate cancer spreads beyond the prostate, symptoms from prostate cancer depend on where it has traveled.
| Site of Spread | Symptoms |
|---|---|
| Bones (most common) | Bone pain (often in the back, hips, pelvis, or ribs); fractures; spinal cord compression (weakness/numbness in legs) |
| Lymph nodes | Swelling in the legs or pelvic area |
| Liver | Jaundice (yellowing of skin/eyes); abdominal pain |
| Lungs | Shortness of breath; persistent cough; chest pain |
General Advanced Symptoms
- Unexplained weight loss
- Fatigue that does not improve with rest
- Nausea and vomiting
- Loss of appetite
Important Warning About Symptom Overlap
Many of the urinary prostate cancer sympotms (a common misspelling) are also caused by benign (non-cancerous) conditions, especially:
- Benign Prostatic Hyperplasia (BPH): Age-related prostate enlargement
- Prostatitis: Inflammation or infection of the prostate
Having urinary symptoms does NOT mean you have prostate cancer. However, it does mean you should see a doctor for evaluation.
The bottom line: Early-stage prostate cancer rarely causes symptoms. By the time prostate cancer symptoms appear, the disease may have advanced. This is why prostate cancer screening is so important, even for men without symptoms.
Part 3: Prostate Cancer Screening – Who, When, and How
Because signs of prostate cancer often do not appear until later stages, regular prostate cancer screening is essential for early detection.
The Two Main Screening Tests
| Test | What It Does | How It Is Done |
|---|---|---|
| PSA Blood Test | Measures prostate-specific antigen, a protein produced by the prostate | Simple blood draw |
| Digital Rectal Exam (DRE) | Doctor feels the prostate for lumps, hardness, or irregular shape | Insertion of a gloved, lubricated finger into the rectum |
The PSA Controversy
The PSA test is sensitive but not perfect. Elevated PSA levels can be caused by:
- Prostate cancer
- BPH (benign enlargement)
- Prostatitis (inflammation)
- Recent ejaculation
- Certain medical procedures
- Age (PSA naturally rises with age)
This means the PSA test can produce false positives (suggesting cancer when none exists) and false negatives (missing cancer that is present). Despite these limitations, the PSA test remains the best available screening tool when used appropriately.
Current Screening Guidelines
Screening recommendations vary by organization. The American Cancer Society (ACS) recommends:
| Age Group | Recommendation |
|---|---|
| Age 40-45 (high risk) | Begin discussing screening with a doctor if you have a strong family history of prostate cancer (father, brother) or are of African American descent |
| Age 50 (average risk) | Begin discussing screening with a doctor |
Shared Decision-Making
Prostate cancer screening should be a shared decision between you and your doctor. Together, you will weigh:
- Benefits: Early detection saves lives
- Risks: False positives, anxiety, unnecessary biopsies, and treatment of cancers that might never have caused harm (overdiagnosis)
What Happens If Screening Is Abnormal?
If the PSA is elevated or the DRE feels abnormal:
- Repeat the PSA test (to rule out temporary elevation)
- Consider additional tests (free PSA, PSA density, biomarkers)
- Recommend a prostate biopsy (the only definitive way to diagnose prostate cancer)
Part 4: Diagnosing Prostate Cancer
If screening raises suspicion, a definitive diagnosis requires a biopsy.
The Biopsy Procedure
- Performed by a urologist
- Ultrasound-guided needles take small tissue samples from the prostate (typically 12-14 cores)
- Performed in a doctor’s office with local anesthesia
- Tissue is examined under a microscope by a pathologist
Gleason Score and Grade Groups
When cancer is found, the pathologist assigns a Gleason score based on how abnormal the cells look. Scores range from 6 (low-grade, slow-growing) to 10 (high-grade, aggressive).
| Gleason Score | Grade Group | Risk Level |
|---|---|---|
| 6 | Grade Group 1 | Low risk (very slow growing) |
| 7 (3+4) | Grade Group 2 | Intermediate favorable |
| 7 (4+3) | Grade Group 3 | Intermediate unfavorable |
| 8 | Grade Group 4 | High risk |
| 9-10 | Grade Group 5 | Very high risk (aggressive) |
Staging
Staging describes how far the cancer has spread:
- Stage I: Confined to the prostate; low Gleason score
- Stage II: Confined to the prostate but larger or higher grade
- Stage III: Grown outside the prostate into nearby tissues
- Stage IV: Spread to lymph nodes or distant organs (metastatic)
Staging guides prostate cancer treatment decisions.
Part 5: Prostate Cancer Treatment Options
Prostate cancer treatment depends on multiple factors: the stage and grade of the cancer, your age, your overall health, and your personal preferences. Treatment options range from active surveillance (watching and waiting) to aggressive local and systemic therapies.
Treatment Options by Risk Level
| Risk Level | Common Treatment Approaches |
|---|---|
| Low risk | Active surveillance; watchful waiting |
| Intermediate risk | Surgery (radical prostatectomy) or radiation therapy ± hormone therapy |
| High risk | Radiation + hormone therapy; surgery ± radiation ± hormone therapy |
| Metastatic (Stage IV) | Hormone therapy (ADT); chemotherapy; newer targeted therapies; immunotherapy |
Active Surveillance (For Low-Risk Cancer)
This is NOT “doing nothing.” It is active monitoring:
- Regular PSA tests (every 6-12 months)
- Repeat biopsies (every 1-3 years)
- Treatment is only started if the cancer shows signs of progression
Best for: Men with low-risk, slow-growing prostate cancer who want to avoid treatment side effects.
Surgery: Radical Prostatectomy
The entire prostate gland and some surrounding tissue are surgically removed.
- Approaches: Robotic-assisted (Da Vinci), laparoscopic, or open surgery
- Hospital stay: 1-2 days
- Risks: Erectile dysfunction (up to 80% temporary, 10-30% permanent); urinary incontinence (5-15% long-term)
- Best for: Localized prostate cancer in men with a life expectancy of 10+ years
Radiation Therapy
High-energy rays kill cancer cells. Two main types:
| Type | How It Works | Schedule |
|---|---|---|
| External Beam Radiation (EBRT) | Machine directs radiation from outside the body | Daily for 4-9 weeks |
| Brachytherapy | Tiny radioactive seeds implanted directly into the prostate | One-time outpatient procedure |
Risks: Urinary irritation, bowel problems, erectile dysfunction (lower risk than surgery).
Hormone Therapy (Androgen Deprivation Therapy – ADT)
Prostate cancer cells need testosterone to grow. Hormone therapy reduces testosterone levels in the body.
- How it is given: Injections (monthly to every 6 months); pills; surgical removal of testicles (rare)
- Side effects: Hot flashes, loss of libido, erectile dysfunction, fatigue, weight gain, bone thinning
- Best for: Advanced or high-risk prostate cancer; used with radiation
Chemotherapy
Drugs that kill rapidly dividing cells. Used primarily for metastatic prostate cancer that no longer responds to hormone therapy.
- Common drug: Docetaxel (Taxotere)
- Side effects: Fatigue, nausea, hair loss, low blood counts (increased infection risk)
Newer and Targeted Therapies
| Therapy | How It Works | Best For |
|---|---|---|
| Enzalutamide (Xtandi) | Blocks androgen receptors | Advanced/metastatic |
| Abiraterone (Zytiga) | Blocks testosterone production | Advanced/metastatic |
| Radium-223 (Xofigo) | Targets bone metastases | Prostate cancer that has spread to bones |
| Immunotherapy (Provenge) | Trains immune system to attack cancer | Advanced, hard-to-treat cases |
| PARP inhibitors (Lynparza, Rubraca) | Blocks DNA repair in cancer cells | Specific genetic mutations (BRCA) |
Focal Therapy (Emerging)
Newer, less invasive treatments target only the cancerous part of the prostate, leaving healthy tissue alone. Examples include:
- High-Intensity Focused Ultrasound (HIFU)
- Cryotherapy (freezing)
- Laser ablation
These are promising but not yet considered standard of care for most patients.
Prostate Cancer Treatment – Side Effect Management
| Side Effect | Management Strategies |
|---|---|
| Erectile dysfunction | PDE5 inhibitors (Viagra, Cialis); vacuum devices; penile injections; implants |
| Urinary incontinence | Pelvic floor exercises (Kegels); medications; sling procedures; artificial urinary sphincter |
| Hot flashes | Medications (low-dose antidepressants, gabapentin); lifestyle changes |
| Fatigue | Regular exercise; energy conservation strategies; treat underlying anemia |
Part 6: Prostate Cancer Survival Rate
The prostate cancer survival rate is one of the most encouraging statistics in oncology—especially when the disease is caught early.
5-Year Relative Survival Rates by Stage
According to the American Cancer Society (based on SEER data from 2014-2020):
| Stage at Diagnosis | 5-Year Relative Survival Rate |
|---|---|
| Localized (confined to prostate) | Nearly 100% |
| Regional (spread to nearby lymph nodes) | Nearly 100% |
| Distant (metastatic – spread to bones or distant organs) | 37% |
| All stages combined | 97.5% |
What These Numbers Mean
- A 97.5% overall 5-year survival rate means that out of 100 men diagnosed with prostate cancer, about 98 are still alive 5 years later
- For localized and regional disease, survival is essentially 100% – these men die of other causes, not prostate cancer
- Even for metastatic disease, survival has improved dramatically with new treatments (from 29% in the 1990s to 37% today)
The “Relative” Survival Rate Explained
The prostate cancer survival rate is “relative” because it compares men with prostate cancer to men of the same age without prostate cancer. This accounts for the fact that older men may die of heart disease, stroke, or other age-related illnesses.
Long-Term Survival
Because prostate cancer is often slow-growing, 10-year and 15-year survival rates are also excellent for localized disease:
- 10-year survival for localized disease: 98-99%
- 15-year survival for localized disease: 95-96%
Factors That Affect Survival
- Gleason score/grade: Low-grade (6) has excellent outcomes; high-grade (9-10) is more aggressive
- PSA level at diagnosis: Very high PSA (>20) is associated with worse outcomes
- Stage: Metastatic disease has lower survival
- Age and overall health: Younger, healthier men tolerate treatment better
- Response to treatment: How well the cancer responds to initial therapy
Part 7: Risk Factors for Prostate Cancer
Understanding risk factors helps you know when to start prostate cancer screening.
Non-Modifiable Risk Factors (Cannot Change)
| Risk Factor | Details |
|---|---|
| Age | Risk increases dramatically after age 50. Most cases diagnosed in men over 65. |
| Family history | Having a father or brother with prostate cancer doubles your risk. Having two first-degree relatives increases risk 5-fold. |
| Genetics | BRCA1, BRCA2, HOXB13 gene mutations; Lynch syndrome |
| Race/ethnicity | African American men have the highest prostate cancer risk in the world (60% higher than white men) and are more likely to develop aggressive cancer at younger ages |
| Geography | North America and Europe have higher rates than Asia |
Modifiable Risk Factors (You Can Change)
| Factor | Evidence |
|---|---|
| Diet | High-fat, high-dairy diets may increase risk; lycopene-rich foods (tomatoes) may decrease risk |
| Obesity | Linked to more aggressive prostate cancer |
| Smoking | Associated with higher mortality from prostate cancer |
| Physical inactivity | Regular exercise may reduce risk |
| Calcium intake | Very high calcium intake (from supplements or dairy) may increase risk |
What Does NOT Cause Prostate Cancer?
- Vasectomy
- Frequent ejaculation
- Prostatitis
- BPH (benign enlargement)
Part 8: Prostate Cancer vs. BPH – Understanding the Difference
Many men confuse prostate cancer symptoms with symptoms of benign prostatic hyperplasia (BPH). Here is how they differ:
| Feature | Prostate Cancer | BPH (Benign Enlargement) |
|---|---|---|
| Is it cancer? | Yes | No |
| Causes urinary symptoms? | Often not until advanced | Yes, very common |
| PSA level | May be elevated | May be elevated |
| DRE (digital rectal exam) | Hard, irregular, nodular | Smooth, firm, symmetrically enlarged |
| Biopsy result | Cancer cells present | Benign cells only |
| Risk of death | Possible (depending on stage) | None (quality of life issue only) |
The key takeaway: Urinary symptoms alone do NOT mean you have prostate cancer. But any man with urinary symptoms should see a doctor for evaluation, which will likely include both PSA testing and a DRE.
Part 9: Living with Prostate Cancer – Beyond Treatment
Surviving prostate cancer is about more than just eliminating the disease. It is about quality of life.
Life After Treatment
Managing long-term side effects:
- Sexual health: Erectile dysfunction is common after surgery and radiation. Options include oral medications (Viagra, Cialis), vacuum devices, injections, or penile implants.
- Bladder control: Stress incontinence (leaking with coughing/sneezing) or urge incontinence (sudden need to go). Pelvic floor physical therapy (Kegel exercises) is highly effective.
- Bowel function: Radiation can cause diarrhea, urgency, or rectal bleeding. Dietary changes and medications can help.
Emotional and Mental Health
A prostate cancer diagnosis is stressful. Anxiety, depression, and fear of recurrence are common. Support is available:
- Prostate cancer support groups (in-person and online)
- Individual counseling or therapy
- Couples counseling (prostate cancer affects partners too)
Follow-Up Care
After treatment, men need regular follow-up:
- PSA tests every 6-12 months (depending on risk)
- Digital rectal exams as recommended
- Imaging (CT, bone scan, or PSMA PET) if PSA rises
A rising PSA after treatment (biochemical recurrence) does not always mean the cancer has returned, but it requires further evaluation.
Part 10: Prevention and Early Detection – Your Best Defense
Because prostate cancer symptoms often appear late, prevention and early detection are critical.
Can Prostate Cancer Be Prevented?
There is no guaranteed way to prevent prostate cancer, but these steps may reduce your risk:
- Eat a plant-based diet: Focus on fruits, vegetables (especially tomatoes/cooked tomato products for lycopene), whole grains, and legumes
- Limit red meat and high-fat dairy
- Maintain a healthy weight
- Exercise regularly (at least 150 minutes of moderate activity per week)
- Quit smoking
- Consider medications if high risk (5-alpha reductase inhibitors like finasteride reduce risk but have side effects)
The Most Important Step: Screening
Prostate cancer screening saves lives. Talk to your doctor about starting screening at:
- Age 40-45 if you are African American or have a strong family history
- Age 50 for average-risk men
Screening is a personal decision. Discuss the benefits and risks with your doctor, but do not ignore it. Prostate cancer is highly curable when caught early—and the prostate cancer survival rate for localized disease is proof.
Part 11: Complete Keyword Reference
This article has covered all requested keywords:
| Keyword | Covered In |
|---|---|
| prostate cancer | Part 1 |
| prostate cancer symptoms | Part 2 |
| prostate cancer treatment | Part 5 |
| signs of prostate cancer | Part 2 |
| symptoms of prostate cancer | Part 2 |
| prostate cancer survival rate | Part 6 |
| what is prostate cancer | Part 1 |
| symptoms from prostate cancer | Part 2 |
| prostate cancer screening | Part 3 |
| prostate cancer sympotms (typo) | Part 2 (note) |
Final Summary: Key Takeaways
| Question | Answer |
|---|---|
| What is prostate cancer? | Uncontrolled growth of cells in the prostate gland |
| What are early symptoms? | Often none. Later: urinary changes, blood in urine/semen, erectile dysfunction |
| How is it detected? | PSA blood test + digital rectal exam (screening); biopsy (diagnosis) |
| What is the survival rate? | 97.5% overall; nearly 100% if caught early |
| Who should be screened? | Men 50+ (average risk); 40-45 (high risk: African American or family history) |
| Is it curable? | Yes, when localized. Advanced cancer is treatable but not always curable |
Final Words
Prostate cancer is common, but it is also one of the most survivable cancers when detected early. The key is understanding what is prostate cancer, recognizing potential prostate cancer symptoms (and knowing that early cancer often has none), and following prostate cancer screening guidelines appropriate for your age and risk.
If you are diagnosed, know that prostate cancer treatment has advanced significantly. From active surveillance to robotic surgery to targeted therapies, options are better than ever. And the prostate cancer survival rate—especially for localized disease—is a testament to that progress.
Do not wait for signs of prostate cancer to appear. By then, the disease may have advanced. Talk to your doctor today about whether prostate cancer screening is right for you.
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider for diagnosis, treatment, and screening decisions. Prostate cancer screening recommendations vary; discuss your individual risk factors with your doctor.
